equityhold
T2T.F
Trust-weighted public proof page for T2T.F. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.
Opportunity
19 / 100
Current score
0.32
Thesis calls
1
Active ticker theses
1
Recent proof-backed thesis calls
Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.
Post announces Anthropic’s new grant call: up to $50K in Claude usage credits for researchers/early-stage biotechs working on rare genetic diseases, as part of its AI-for-Science program. This is informative about AI tooling adoption in biomedical research but contains no public-company-specific claims or catalysts tied to tradable tickers.
Mentioned: Jul 20, 2026, 1:54 PM EDTConviction: 32 / 100Observed price: $5.20 on 2026-07-20Return: 0.20%
Source: Nathan C. Frey @nc_frey 1h Today, we're opening a call for applications focused on rare genetic diseases. This progra...
Current stance
Recommendationhold
Authors1
Active ticker theses1
Latest pricen/a
Why now
- buy via Fundamental acceleration supports NFA.F-led basket from https://x.com/citrini (confidence 0.32)
Top authors on this asset
Active and historical ticker theses
Unlock full asset monitoring
Create an account to access full asset history, alerts, Telegram workflows, and trust-weighted live rankings across authors, ticker theses, and market events.